273 related articles for article (PubMed ID: 20643169)
1. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
[TBL] [Abstract][Full Text] [Related]
2. Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia.
Simón-Yarza T; Tamayo E; Benavides C; Lana H; Formiga FR; Grama CN; Ortiz-de-Solorzano C; Kumar MN; Prosper F; Blanco-Prieto MJ
Int J Pharm; 2013 Oct; 454(2):784-90. PubMed ID: 23639291
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
4. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
5. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
[TBL] [Abstract][Full Text] [Related]
6. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on polylactic glycolate acid microparticles with releasing-slowly vascular endothelial growth factor].
Chen Y; Luo X; Xiao J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Apr; 19(4):262-3. PubMed ID: 15921313
[TBL] [Abstract][Full Text] [Related]
8. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
[TBL] [Abstract][Full Text] [Related]
9. Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.
Chung HJ; Kim JT; Kim HJ; Kyung HW; Katila P; Lee JH; Yang TH; Yang YI; Lee SJ
J Control Release; 2015 May; 205():218-30. PubMed ID: 25681051
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery.
Yi F; Wu H; Jia GL
J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119
[TBL] [Abstract][Full Text] [Related]
11. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
12. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia.
Formiga FR; Garbayo E; Díaz-Herráez P; Abizanda G; Simón-Yarza T; Tamayo E; Prósper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):665-72. PubMed ID: 23523545
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
14. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
Liu CD; Tu XF; Chen F
Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
[TBL] [Abstract][Full Text] [Related]
16. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
17. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
18. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
19. Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts.
Pascual-Gil S; Simón-Yarza T; Garbayo E; Prosper F; Blanco-Prieto MJ
J Control Release; 2015 Dec; 220(Pt A):388-396. PubMed ID: 26546270
[TBL] [Abstract][Full Text] [Related]
20. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
